Sign In
Buy MRK
$120.78
+1.69 (+1.41%)
At Close: Jun 11, 2026
1248 Management LLC Has $162,000 Holdings in Merck & Co., Inc. $MRK
04:12am, Sunday, 15'th Mar 2026
1248 Management LLC cut its stake in Merck and Co., Inc. (NYSE: MRK) by 81.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC)
Investors Buy Large Volume of Merck & Co., Inc. Call Options (NYSE:MRK)
02:06am, Sunday, 15'th Mar 2026
Merck and Co., Inc. (NYSE: MRK - Get Free Report) saw unusually large options trading on Friday. Stock traders bought 672,962 call options on the company. This represents an increase of 1,339% compare
Glenmede Investment Management LP Has $45.31 Million Stock Holdings in Merck & Co., Inc. $MRK
08:10am, Saturday, 14'th Mar 2026
Glenmede Investment Management LP trimmed its stake in Merck and Co., Inc. (NYSE: MRK) by 14.2% in the third quarter, according to the company in its most recent disclosure with the Securities and Exc
Brown Brothers Harriman & Co. Purchases 7,463 Shares of Merck & Co., Inc. $MRK
04:06am, Saturday, 14'th Mar 2026
Brown Brothers Harriman and Co. boosted its position in shares of Merck and Co., Inc. (NYSE: MRK) by 3.6% in the third quarter, according to the company in its most recent disclosure with the Securiti
Merck & Co., Inc. $MRK is Arrowstreet Capital Limited Partnership’s 10th Largest Position
03:58am, Friday, 13'th Mar 2026
Arrowstreet Capital Limited Partnership cut its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 3.8% during the undefined quarter, according to the company in its most recent 13F filing with the
Merck Price Prediction: Sac-TMT Drug Potential Pushes MRK to $150
11:14am, Thursday, 12'th Mar 2026
Merck & Co., Inc. ( NYSE:MRK ) has been on a strong recovery run, gaining 23% over the past year and 8% year-to-date, though the stock has pulled back some, now well below its 52-week high of $125.14.
Capital Group Private Client Services Inc. Lowers Stock Position in Merck & Co., Inc. $MRK
04:42am, Thursday, 12'th Mar 2026
Capital Group Private Client Services Inc. trimmed its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 94.1% during the undefined quarter, according to the company in its most recent Form 13F
Capital International Inc. CA Cuts Position in Merck & Co., Inc. $MRK
04:09am, Thursday, 12'th Mar 2026
Capital International Inc. CA trimmed its position in shares of Merck and Co., Inc. (NYSE: MRK) by 37.5% during the undefined quarter, according to its most recent 13F filing with the Securities and E
Harbor Health Care ETF Q4 2025 Portfolio Review
08:18am, Wednesday, 11'th Mar 2026
Revolution Medicines was a top contributor during the quarter. AbbVie, by contrast, traded largely sideways, as investors continued to assess its post-patent earnings durability. While Eli Lilly deliv
Merck & Co., Inc. $MRK Shares Sold by Beese Fulmer Investment Management Inc.
04:53am, Wednesday, 11'th Mar 2026
Beese Fulmer Investment Management Inc. decreased its position in Merck and Co., Inc. (NYSE: MRK) by 7.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange
Merck & Co., Inc. $MRK Shares Sold by Barrow Hanley Mewhinney & Strauss LLC
04:52am, Wednesday, 11'th Mar 2026
Barrow Hanley Mewhinney and Strauss LLC lessened its position in shares of Merck and Co., Inc. (NYSE: MRK) by 14.8% during the third quarter, according to the company in its most recent 13F filing wit
Diversify Advisory Services LLC Cuts Holdings in Merck & Co., Inc. $MRK
04:12am, Wednesday, 11'th Mar 2026
Diversify Advisory Services LLC reduced its position in shares of Merck and Co., Inc. (NYSE: MRK) by 38.4% in the undefined quarter, according to the company in its most recent 13F filing with the Sec
Merck (MRK) Rises Higher Than Market: Key Facts
06:46pm, Monday, 09'th Mar 2026
The latest trading day saw Merck (MRK) settling at $117.11, representing a +1.14% change from its previous close.
Will Weak Gardasil Sales Continue to Weigh on MRK's Top Line in 2026?
10:35am, Monday, 09'th Mar 2026
Merck faces continued pressure as Gardasil sales slump 39% in 2025, hit by weak China demand, with management expecting no rebound in 2026.
DLD Asset Management LP Has $3.99 Billion Stock Position in Merck & Co., Inc. $MRK
05:40am, Monday, 09'th Mar 2026
DLD Asset Management LP raised its holdings in Merck and Co., Inc. (NYSE: MRK) by 30.1% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (S
